Some rare diseases such as monogenic obesity due to leptin-melanocortin pathway anomaly have also been of special interest as understanding this specific pathway might lead to therapeutic innovations or etiologic insights in other, more common, forms of obesity [21]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.